ATM missense mutations are frequent inpatients with breast cancer
- 1 September 2003
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 145 (2) , 115-120
- https://doi.org/10.1016/s0165-4608(03)00119-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controlsCancer Genetics and Cytogenetics, 2002
- Dominant Negative ATM Mutations in Breast Cancer FamiliesJNCI Journal of the National Cancer Institute, 2002
- Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancerProceedings of the National Academy of Sciences, 2002
- Recent trends in breast cancer incidence and mortalityEnvironmental and Molecular Mutagenesis, 2002
- Breast cancer genetics: What we know and what we needNature Medicine, 2001
- ATM Mutations and Phenotypes in Ataxia-Telangiectasia Families in the British Isles: Expression of Mutant ATM and the Risk of Leukemia, Lymphoma, and Breast CancerAmerican Journal of Human Genetics, 1998
- Heterozygous ATM mutations do not contribute to early onset of breast cancerNature Genetics, 1997
- Diversity ofATM gene mutations detected in patients with ataxia-telangiectasiaHuman Mutation, 1997
- A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 KinaseScience, 1995
- Incidence of Cancer in 161 Families Affected by Ataxia–TelangiectasiaNew England Journal of Medicine, 1991